^
    BIOMARKER:

    CRLF2 rearrangement

    i
    Other names: CRLF2, Cytokine Receptor Like Factor 2, Thymic Stromal Lymphopoietin Protein Receptor, Cytokine Receptor-Like Factor 2, TSLP Receptor, IL-XR, TSLPR, CRL2, Thymic Stromal-Derived Lymphopoietin Receptor, Cytokine Receptor CRL2 Precusor, Cytokine Receptor-Like 2, CRLF2Y, ILXR
    Entrez ID:
    64109
    Related biomarkers:
    Expression
    Mutation
    Fusion
    Others
    CRLF2 rearrangement
    ALL
    T-lymphocyte cell therapy + ruxolitinib
    Sensitive: C2 – Inclusion Criteria
    EHA 2022 - 2 weeks - (New C3)
    CRLF2 rearrangement
    ALL
    T-lymphocyte cell therapy
    Sensitive: C3 – Early Trials
    EHA 2022 - 2 weeks - (New C3)
    CRLF2 rearrangement
    ALL
    ruxolitinib
    Sensitive: C2 – Inclusion Criteria
    CRLF2 rearrangement
    AML
    ruxolitinib
    Sensitive: D – Preclinical